James Woody

180 Life Sciences Corp. (NASDAQ: ATNF) filed a provisional patent describing the novel combination of CBD, or an analog thereof, with glucagon related peptide-1 (GLP-1) agonists to address the problem of obesity and weight management. CBD has been shown to reduce inflammation and stimulate satiety...